Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults
Phase 2
108
about 3 years
18–45
1 site in AZ
What this study is about
Researchers are testing whether a marijuana-based drug helps with anxiety in autistic adults. The trial is comparing the drug to a placebo (an inactive substance) to see if it reduces symptoms of anxiety. Participants will take the drug or placebo daily for 8 weeks, keeping a diary and attending clinic visits.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take MB-IMP
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in baseline on reported anxiety related symptoms
Psychiatry / Mental Health